Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
Sen. On CNBC's "Mad Money Lightning Round," Jim Cramer said Uranium Energy Corp. (NYSE:UEC) is going higher. "UEC's the real deal...We need more uranium. I think it's a great situation," he added.
在CNBC的"瘋狂金錢雷電回合"中，吉姆·克雷默表示鈾能源公司（NYSE:UEC）將會繼續上漲。"UEC是真正的交易...我們需要更多鈾。我認爲這是一個很好的情況，"他補充道。
On Sept. 23, Uranium Energy disclosed a deal to fully acquire Rio Tinto Plc's (NYSE:RIO) Wyoming assets for a purchase price of $175 million. As per the deal, the buyout includes the fully licensed Sweetwater Plant and a portfolio of uranium mining projects with around 175 million pounds of historic resources.
9月23日，鈾能源披露了一份協議，完全收購力拓公司（NYSE:RIO）的懷俄明資產，以價值17500萬美元的收購價。根據協議，收購包括完全持牌的Sweetwater工廠和一系列擁有大約17500萬磅歷史資源的鈾採礦項目。
When asked about Novo Nordisk (NYSE:NVO), he said, "Doesn't hold a candle to Eli Lilly (NYSE:LLY)."
當被問及諾和諾德（NYSE:NVO）時，他表示，"無法與禮來（NYSE:LLY）相提並論。"
Sen. Elizabeth Warren (D-MA), last week, wrote a letter to the Federal Trade Commission's chair, Lina Khan, urging the department to investigate Novo Nordisk's proposed $16.5 billion acquisition of contract development and manufacturing organization Catalent Inc (NYSE:CTLT) thoroughly, amid growing concerns about potential antitrust violations. Critics argue that this merger could increase Novo Nordisk's control over producing vital GLP-1 receptor agonists, drugs used to treat diabetes and obesity. This could potentially drive up prices and limit competition.
上週，馬薩諸塞州參議員伊麗莎白·禾倫致信聯邦貿易委員會主席麗娜·卡恩，敦促該部門對諾和諾德擬議的165億美元收購合同開發製造組織卡特倫特公司（NYSE:CTLT）進行徹底調查，日益關注潛在的反壟斷違規行爲。批評人士認爲，這一合併可能增加諾和諾德對生產重要GLP-1受體激動劑的控制，這些藥物用於治療糖尿病和肥胖。這可能會推高價格並限制競爭。
Cramer recommended staying away from Halliburton (NYSE:HAL).
克雷默建議避開哈里伯頓（NYSE:HAL）。
On Monday, BofA Securities analyst Chase Mulvehill maintained Halliburton with a Buy rating and lowered the price target from $40 to $38.
週一，美銀證券分析師切斯·馬爾維爾維爾給哈里伯頓維持買入評級，將目標價從40美元降至38美元。
Price Action:
價格行動：
- Novo Nordisk shares fell 0.2% to settle at $119.78 on Monday.
- Uranium Energy shares gained 0.7% to close at $7.14.
- Halliburton shares fell 0.8% to close at $30.58 on Monday.
- 週一，諾和諾德股價下跌0.2%，收於119.78美元。
- 鈾能源股份上漲0.7%，收盤價爲7.14美元。
- 哈里伯頓股份週一下跌0.8%，收盤價爲30.58美元。
- Wall Street's Most Accurate Analysts Weigh In On 3 Tech And Telecom Stocks With Over 4% Dividend Yields
- 華爾街最準確的分析師們對3家科技和電信股票的意見，這些股票的股息率超過4％。
Photo: Shutterstock
Photo: shutterstock
